BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 33399232)

  • 1. PDP1 promotes the progression of breast cancer through STAT3 pathway.
    Wang Y; Dang H; Qiao H; Tian Y; Guan Q
    Cell Biochem Funct; 2024 Apr; 42(3):e3994. PubMed ID: 38566355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation regulates hnRNPA2 granule protein partitioning and reduces neurodegeneration.
    Ryan VH; Perdikari TM; Naik MT; Saueressig CF; Lins J; Dignon GL; Mittal J; Hart AC; Fawzi NL
    EMBO J; 2021 Feb; 40(3):e105001. PubMed ID: 33349959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
    Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
    J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2021 Mar; 40(1):111. PubMed ID: 33757526
    [No Abstract]   [Full Text] [Related]  

  • 5. hnRNPA2B1 Promotes Colon Cancer Progression via the MAPK Pathway.
    Tang J; Chen Z; Wang Q; Hao W; Gao WQ; Xu H
    Front Genet; 2021; 12():666451. PubMed ID: 34630502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL14‑mediated RNA methylation in digestive system tumors.
    Hu J; Lin H; Wang C; Su Q; Cao B
    Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37539726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
    Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
    Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape.
    Sudhakaran M; Doseff AI
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
    Ruffenach G; Medzikovic L; Aryan L; Li M; Eghbali M
    Circulation; 2022 Oct; 146(16):1243-1258. PubMed ID: 35993245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.
    Lu Y; Wang X; Gu Q; Wang J; Sui Y; Wu J; Feng J
    Cell Death Discov; 2022 Jul; 8(1):337. PubMed ID: 35879279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
    Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
    Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma.
    Liu R; Shen Y; Hu J; Wang X; Wu D; Zhai M; Bai J; He A
    Front Oncol; 2021; 11():731957. PubMed ID: 34804925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HnRNPA2B1 promotes the proliferation of breast cancer MCF-7 cells via the STAT3 pathway.
    Gao LB; Zhu XL; Shi JX; Yang L; Xu ZQ; Shi SL
    J Cell Biochem; 2021 Apr; 122(3-4):472-484. PubMed ID: 33399232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hnRNPA2/B1 on the proliferation and apoptosis of glioma U251 cells via the regulation of AKT and STAT3 pathways.
    Yin D; Kong C; Chen M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways.
    Liu Y; Li H; Liu F; Gao LB; Han R; Chen C; Ding X; Li S; Lu K; Yang L; Tian HM; Chen BB; Li X; Xu DH; Deng XL; Shi SL
    EBioMedicine; 2020 Jan; 51():102583. PubMed ID: 31901866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.
    Klinge CM; Piell KM; Tooley CS; Rouchka EC
    Sci Rep; 2019 Jul; 9(1):9430. PubMed ID: 31263129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.
    Xuan Y; Wang J; Ban L; Lu JJ; Yi C; Li Z; Yu W; Li M; Xu T; Yang W; Tang Z; Tang R; Xiao X; Meng S; Chen Y; Liu Q; Huang W; Guo W; Cui X; Deng W
    Mol Oncol; 2016 Apr; 10(4):610-24. PubMed ID: 26774881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
    Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
    Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.